Showing results (271-280 of 281) with videos related to
Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M Federico, Alberto S Pappo, Natasha Sahr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2017
Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology GroupAllison F O'Neill, Alexander J Towbin, Mark D Krailo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastomaFariba Navid, Paul M Sondel, Raymond Barfield, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322AWayne L Furman, Beth McCarville, Barry L Shulkin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.Journal of Pediatric Surgery|July 9, 2022
Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731Sanjeev A Vasudevan, Rebecka L Meyers, Milton J Finegold, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2021
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study CommitteeAngela Trobaugh-Lotrario, Howard M Katzenstein, Sarangarajan Ranganathan, et al.Pediatric Blood & Cancer|April 19, 2023
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study CommitteePatrick A Thompson, Marcio H Malogolowkin, Wayne L Furman, et al.Cancer|November 11, 2021
Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group studyHoward M Katzenstein, Marcio H Malogolowkin, Mark D Krailo, et al.Annals of Surgery|September 25, 2025
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III TrialZachary J Kastenberg, Sanjeev A Vasudevan, Lucy Dolmadjian, et al.Pageof 29